NewsDetails

Rachel Darwin, Senior Manager, Public Relations Leading oncology experts explain the reasons for joining a cancer clinical trial and provide information on how to make it happen. PLYMOUTH MEETING, PA [March 17, 2025] The National Comprehensive Cancer Network ® (NCCN ®) is sharing a webinar today that answers critical patient questions about cancer clinical trials. The newly released, on-demand webinar is titled “Why Should I Consider a Clinical Trial?” It is available for free at NCCN.org/patientwebinars

Read the full article here

Source: www.nccn.org

Categories: Oncologists1, General Medicine News

Tags: ClinicalTrials,oncology

Tweets with this article

National Comprehensive Cancer Network (NCCN)

NCCN Foundation webinar explains why people with cancer should consider participating in clinical trials and how to make it happen. Learn more: https://t.co/1e8HdIbNP1 #ClinicalTrials #Oncology https://t.co/K68tqhfKak

Webinars for Patients

NCCN Webinars for Patients feature experts as they discuss the best care for different cancer types.

National Comprehensive Cancer Network (NCCN) April 16, 2025

This link will take you to a page that’s not on LinkedIn

National Comprehensive Cancer Network (NCCN) April 11, 2025

NewsDetails

Rachel Darwin, Senior Manager, Public Relations Researchers at The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center found socially vulnerable patients with…

National Comprehensive Cancer Network (NCCN) April 9, 2025

Annual Conference

The NCCN Annual Conference is a CE-certified conference that features live and on-demand educational sessions focusing on a variety of topics in oncology.

National Comprehensive Cancer Network (NCCN) March 28, 2025

Potential targeted therapy for pediatric brain cancer identified by Dana-Farber/Boston Children’s team | Dana-Farber Cancer Institute

An international team of clinical collaborators, led by physician scientists from Dana-Farber Cancer Institute, performed a first-ever clinical test of the targeted therapy avapritinib in…

Dana-Farber March 20, 2025

Suicidal ideation significantly higher among childhood cancer survivors

Childhood cancer survivors in Europe exhibited higher risk for suicidal ideation than the general population, according to results of a systematic review and meta-analysis.This finding…

HemOnc Today March 20, 2025

Clinical Scenario 1: A HER2+ mBC Patient With Trastuzumab Deruxtecan With Brain Mets

Panelists discuss how trastuzumab deruxtecan (Enhertu) is used to treat HER2-positive metastatic breast cancer with brain metastases, emphasizing its effectiveness in achieving systemic tumor reduction…

OncLive.com March 20, 2025

Peritumoral edema resolves infrequently in surgically treated patients with intracranial meningioma– a retrospective study of 279 meningioma patients

Journal of Neuro-Oncology – The resolution of peritumoral brain edema (PTBE) following surgery for intracranial meningioma (IM) is poorly understood. We hypothesized that PTBE represents…

Journal of Neuro-Oncology March 20, 2025

ASTROgram for week of March 17- American Society for Radiation Oncology (ASTRO)

ASTRO’s weekly member newsletter for the week of March 17: ROCR Act reintroduced, Don’t miss 2025 Refresher, Leadership Pathway Program Awardees

ASTRO March 20, 2025

Genomic Summary Results | EGRP/DCCPS/NCI/NIH

Resources for investigators to find and make publicly available genomic summary results (GSR) data from cancer research studies.

National Cancer Institute March 20, 2025

Related Articles